This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Eli Lilly and Company, The University of Texas System. Active years: 2026.
Company Filing History:
1 out of 4,509 
1 out of 5,633 
Years Active: 2026
Title: Vivian Salama - Innovator in Cancer Therapy
Introduction
Vivian Salama is a notable inventor based in Houston, TX (US). She has made significant contributions to the field of cancer treatment through her innovative research. Although she currently holds no granted patents, her work in combination therapies has the potential to impact the medical community.
Latest Patent Applications
Vivian Salama's latest patent application is titled "Combination Therapy with a Mutant IDH Inhibitor and a BCL-2 Inhibitor." This invention relates to a combination therapy that utilizes a mutant IDH inhibitor of Formula (I) alongside a Bcl-2 inhibitor for the treatment of cancer. This application reflects her commitment to advancing cancer therapies and improving patient outcomes.
Conclusion
Vivian Salama's work exemplifies the innovative spirit in the medical field, particularly in cancer therapy. Her research and applications may pave the way for future advancements in treatment options.